We aimed to compare health care utilization of children with pediatric-onset multiple sclerosis to that of age, sex and geographically-matched children without multiple sclerosis. Using population-based administrative data from Ontario, Canada for the period 2003-2014, we applied a validated case definition to identify persons aged ≤18 years with multiple sclerosis. We identified up to 5 children without multiple sclerosis matched on sex, age, and region of residence. In each cohort, we determined annual rates of any hospitalization and physician services use. Using general linear models we compared utilization rates adjusting for age, sex, region, socioeconomic status and year. Subsequently, we limited the analysis to incident cases of mul...
A case-controlled epidemiologic study of multiple sclerosis (MS) was carried out in London, Ontario,...
About 3-5% of all patients with multiple sclerosis experience the onset of their disease under the a...
Objectives: To describe and compare disease course and prognosis of early (i.e., disease onset befor...
ABSTRACT Objectives Much clinical knowledge about multiple sclerosis (MS) has been gained from pati...
Background. The prevalence of multiple sclerosis (MS) appears to be increasing worldwide. However, d...
Background Although the diagnosis of multiple sclerosis (MS) in the paediatric population remains ch...
The Author(s) 2015. This article is published with open access at Springerlink.com Abstract Province...
International audienceBackground: Onset of multiple sclerosis (MS) before 18 years old, called Paedi...
Abstract From the retrospective study of 3375 patients effected by clinically definite or probable ...
From the retrospective study of 3375 patients affected by clinically definite or probable multiple s...
Multiple sclerosis (MS) is a chronic inflammatory and demyelinating disease of the central nervous s...
Purpose : For chronically ill persons it is assumed that they make heavy demands on health care serv...
My PhD project involved examining the epidemiology and pharmacoepidemiology of multiple sclerosis (M...
BACKGROUND: The course and prognosis of childhood-onset multiple sclerosis have not been well descri...
About 3-5% of all patients with multiple sclerosis experience the onset of their disease under the a...
A case-controlled epidemiologic study of multiple sclerosis (MS) was carried out in London, Ontario,...
About 3-5% of all patients with multiple sclerosis experience the onset of their disease under the a...
Objectives: To describe and compare disease course and prognosis of early (i.e., disease onset befor...
ABSTRACT Objectives Much clinical knowledge about multiple sclerosis (MS) has been gained from pati...
Background. The prevalence of multiple sclerosis (MS) appears to be increasing worldwide. However, d...
Background Although the diagnosis of multiple sclerosis (MS) in the paediatric population remains ch...
The Author(s) 2015. This article is published with open access at Springerlink.com Abstract Province...
International audienceBackground: Onset of multiple sclerosis (MS) before 18 years old, called Paedi...
Abstract From the retrospective study of 3375 patients effected by clinically definite or probable ...
From the retrospective study of 3375 patients affected by clinically definite or probable multiple s...
Multiple sclerosis (MS) is a chronic inflammatory and demyelinating disease of the central nervous s...
Purpose : For chronically ill persons it is assumed that they make heavy demands on health care serv...
My PhD project involved examining the epidemiology and pharmacoepidemiology of multiple sclerosis (M...
BACKGROUND: The course and prognosis of childhood-onset multiple sclerosis have not been well descri...
About 3-5% of all patients with multiple sclerosis experience the onset of their disease under the a...
A case-controlled epidemiologic study of multiple sclerosis (MS) was carried out in London, Ontario,...
About 3-5% of all patients with multiple sclerosis experience the onset of their disease under the a...
Objectives: To describe and compare disease course and prognosis of early (i.e., disease onset befor...